News Sentiment

AMPH sentiment intelligence

Amphastar P news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 47 Balanced news tone 44 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 18.72 Week of 10 Jul 2026
Weighted tone 47/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

77/100 classification confidence.

Company focus 44

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-4.7% over one week, -6.8% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Dimensional Fund Advisors stake in Amphastar Pharmaceuticals (AMPH) hits 5.2%

Market Reaction

Price moving ahead of tone

61/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 77/100 classification
One-week reaction -4.7% Price reacting lower
Trend fit Trend inactive -6.8% over four weeks
Fair value -48.5% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 5
Neutral 27
Negative 12

Relevance

Why the article matched

Direct first
Direct company coverage 44
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TradingView 12
Market source 7
Stock Titan 6
TradingKey 6
MT Newswires 2
Investing.com 2
Investing.com Canada 1
Seeking Alpha 1

Event Lens

What the news is about

Classified themes
Market update 21
Earnings 13
Analyst action 4
Regulatory and legal 2
Guidance 2
Deals and strategy 1
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-44 of 44
Stock Traders Daily Direct company coverage

(AMPH) Price Dynamics and Execution-Aware Positioning

This article provides an in-depth analysis of Amphastar Pharmaceuticals Inc. (NASDAQ: AMPH) stock, highlighting strong near and mid-term sentiment but a weak long-term outlook. It details three AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—

Tone
Neutral 50/100
Event
Guidance
Published
13 Jun 2026 17:40
Source
Stock Traders Daily
Simply Wall Street Direct company coverage

AMPH: Updated Outlook And Q1 Reset Will Support Future Upside Potential

Amphastar Pharmaceuticals has seen its average analyst price target cut from $26.86 to $22.83 following recent Q1 results and a revised 2026 outlook. This adjustment reflects increased uncertainty regarding future revenue and margin projections, particularly concerning the potent

Tone
Negative 34/100
Event
Analyst action
Published
10 Jun 2026 05:39
Source
Simply Wall Street